Accession Number: | 0001104659-20-074349 |
Date: | 2020-06-16 |
Issuer: | CASI PHARMACEUTICALS, INC. (CASI) |
Original Submission Date: |
SALISBURY FRANKLIN CARY JR
CASI PHARMACEUTICALS, INC.
9620 MEDICAL CENTER DR. SUITE 300
ROCKVILLE, MD 20850
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.63 | 2020-06-16 | deemed execution date | A | 68,800 (a) | 2030-06-16 | common stock 68,800 | $2.63 | 68,800 | direct |
ID | footnote |
---|---|
f1 | stock option award will vest ratably quarterly to the end of the year. |